These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34199053)

  • 21. Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers.
    Wi YM; Kim SH; Peck KR
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.
    van Doremalen N; Haddock E; Feldmann F; Meade-White K; Bushmaker T; Fischer RJ; Okumura A; Hanley PW; Saturday G; Edwards NJ; Clark MHA; Lambe T; Gilbert SC; Munster VJ
    Sci Adv; 2020 Jun; 6(24):eaba8399. PubMed ID: 32577525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
    Wilkie M; Satti I; Minhinnick A; Harris S; Riste M; Ramon RL; Sheehan S; Thomas ZM; Wright D; Stockdale L; Hamidi A; O'Shea MK; Dwivedi K; Behrens HM; Davenne T; Morton J; Vermaak S; Lawrie A; Moss P; McShane H
    Vaccine; 2020 Jan; 38(4):779-789. PubMed ID: 31735500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.
    Dispinseri S; Lampasona V; Secchi M; Cara A; Bazzigaluppi E; Negri D; Brigatti C; Pirillo MF; Marzinotto I; Borghi M; Rovere-Querini P; Tresoldi C; Ciceri F; Scavini M; Scarlatti G; Piemonti L
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1472-1481. PubMed ID: 33513242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.
    Kim YJ; Bae JY; Bae S; Hwang S; Kwon KT; Chang HH; Lee WK; Cui C; Lee GE; Kim SW; Park MS
    Yonsei Med J; 2021 Jul; 62(7):584-592. PubMed ID: 34164955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2.
    Lee SW; Lee H; Lee SK; Moon JY; Moon S; Chung SJ; Yeo Y; Park TS; Won Park D; Kim TH; Sohn JW; Yoon HJ; Kim SH
    Front Med (Lausanne); 2021; 8():738049. PubMed ID: 34660644
    [No Abstract]   [Full Text] [Related]  

  • 29. ChAdOx1 SARS-CoV-2 vaccination: A putative precipitant of adrenal crises.
    Maguire D; McLaren DS; Rasool I; Shah PM; Lynch J; Murray RD
    Clin Endocrinol (Oxf); 2023 Nov; 99(5):470-473. PubMed ID: 34358373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological Distress and Physical Adverse Events of COVID-19 Vaccination among Healthcare Workers in Taiwan.
    Rifai A; Wu WC; Tang YW; Lu MY; Chiu PJ; Strong C; Lin CY; Chen PL; Ko WC; Ko NY
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse Effects on Work and Daily Life Interference among Healthcare Workers after the First and Second ChAdOx1 and BNT162b2 COVID-19 Vaccine Doses.
    Park C; Sakong J; Jo S; Kim M; Baek K
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High neutralizing antibody titer in intensive care unit patients with COVID-19.
    Liu L; To KK; Chan KH; Wong YC; Zhou R; Kwan KY; Fong CH; Chen LL; Choi CY; Lu L; Tsang OT; Leung WS; To WK; Hung IF; Yuen KY; Chen Z
    Emerg Microbes Infect; 2020 Dec; 9(1):1664-1670. PubMed ID: 32618497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
    Pottegård A; Lund LC; Karlstad Ø; Dahl J; Andersen M; Hallas J; Lidegaard Ø; Tapia G; Gulseth HL; Ruiz PL; Watle SV; Mikkelsen AP; Pedersen L; Sørensen HT; Thomsen RW; Hviid A
    BMJ; 2021 May; 373():n1114. PubMed ID: 33952445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus and RNA-based COVID-19 vaccines' perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey.
    Temsah MH; Barry M; Aljamaan F; Alhuzaimi A; Al-Eyadhy A; Saddik B; Alrabiaah A; Alsohime F; Alhaboob A; Alhasan K; Alaraj A; Halwani R; Alamro NM; Al-Shahrani FS; Jamal A; Alsubaie S; Memish ZA; Al-Tawfiq JA
    BMJ Open; 2021 Jun; 11(6):e048586. PubMed ID: 34155080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
    Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
    J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
    Jackson LA; Anderson EJ; Rouphael NG; Roberts PC; Makhene M; Coler RN; McCullough MP; Chappell JD; Denison MR; Stevens LJ; Pruijssers AJ; McDermott A; Flach B; Doria-Rose NA; Corbett KS; Morabito KM; O'Dell S; Schmidt SD; Swanson PA; Padilla M; Mascola JR; Neuzil KM; Bennett H; Sun W; Peters E; Makowski M; Albert J; Cross K; Buchanan W; Pikaart-Tautges R; Ledgerwood JE; Graham BS; Beigel JH;
    N Engl J Med; 2020 Nov; 383(20):1920-1931. PubMed ID: 32663912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.
    Marsh GA; McAuley AJ; Au GG; Riddell S; Layton D; Singanallur NB; Layton R; Payne J; Durr PA; Bender H; Barr JA; Bingham J; Boyd V; Brown S; Bruce MP; Burkett K; Eastwood T; Edwards S; Gough T; Halpin K; Harper J; Holmes C; Horman WSJ; van Vuren PJ; Lowther S; Maynard K; McAuley KD; Neave MJ; Poole T; Rootes C; Rowe B; Soldani E; Stevens V; Stewart CR; Suen WW; Tachedjian M; Todd S; Trinidad L; Walter D; Watson N; Drew TW; Gilbert SC; Lambe T; Vasan SS
    NPJ Vaccines; 2021 May; 6(1):67. PubMed ID: 33972565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.